Literature DB >> 1732421

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer.

S A Rosenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1732421     DOI： 10.1200/JCO.1992.10.2.180

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  51 in total

1.  Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes.

Authors:  N G Baldwin; C D Rice; T M Tuttle; H D Bear; J I Hirsch; R E Merchant
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

Review 2.  Immunomodulation following chemotherapy.

Authors:  M Obadina; U Verma; M Hawkins; A Mazumder
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  Immunotherapy II: Antigens, receptors and costimulation.

Authors:  P F Searle; L S Young
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 4.  Vectors for cancer gene therapy.

Authors:  J Zhang; S J Russell
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

Review 5.  New therapeutic approaches based on gene transfer techniques.

Authors:  H Chong; R G Vile
Journal:  Springer Semin Immunopathol       Date:  1996

Review 6.  Monoclonal antibodies in cancer therapy.

Authors:  R Gruber; E Holz; G Riethmüller
Journal:  Springer Semin Immunopathol       Date:  1996

7.  Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.

Authors:  Mark P Rubinstein; Colleen A Cloud; Tracy E Garrett; Caitlin J Moore; Kristina M Schwartz; C Bryce Johnson; David H Craig; Mohamed L Salem; Chrystal M Paulos; David J Cole
Journal:  J Am Coll Surg       Date:  2012-02-22       Impact factor: 6.113

8.  Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha.

Authors:  C N Baxevanis; A D Gritzapis; G Spanakos; O E Tsitsilonis; M Papamichail
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

9.  Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; L Rivoltini; S L Topalian; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin.

Authors:  P Lissoni; S Pittalis; A Ardizzoia; F Brivio; S Barni; G Tancini; F Pelizzoni; G J Maestroni; B Zubelewicz; R Braczkowski
Journal:  Support Care Cancer       Date:  1996-07       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.